Expanding Patient Population Creates a Huge Market for Invasive Pressure Monitoring and Hemodynamic Monitoring, Finds Frost & Sullivan

LONDON - The higher incidence of chronic illnesses in Europe and the consequent
increase of patient population in intensive care units has amplified the need
for equipment that measure vital signs such as blood pressure during
surgeries. This rise in the number of people requiring critical care has
escalated the demand for catheters and transducers.

(Logo: www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost & Sullivan (
www.patientmonitoring.frost.com), European Market for Invasive
Pressure Monitoring and Hemodynamic Monitoring, finds that market earned
revenues of US$336.4 million in 2007 and is estimated to touch US$520.6
million by 2014. In this research, Frost & Sullivan’s expert analysts
thoroughly examine the following markets: central venous catheters, pulmonary
artery catheters and disposable pressure transducers.

If you are interested in a virtual brochure, which provides a brief
synopsis of the research and a table of contents, then send an e-mail to
Katja Feick, Corporate Communications, at katja.feick@frost.com, with your
full name, company name, title, telephone number, company e-mail address,
company website, city, state and country. Upon receipt of the above
information, a brochure will be sent to you by e-mail.

“Hospitals do not consider non-invasive method of blood pressure
monitoring accurate; they prefer continuous invasive blood pressure
monitoring that provides quick and correct readings,” says Frost & Sullivan
Research Analyst Akanksha Joshi. “Therefore, there is significant demand for
disposable pressure transducers and catheters that provide invasive blood
pressure monitoring.”

With both hospitals and patients gravitating towards non-invasive methods
due to their benefits of lower costs and reducing the trauma faced by
patients, smaller incisions, shorter hospital stay and faster recovery,
medical device manufacturers have to innovate constantly to keep pace with
these developments in surgical techniques.

Manufacturers must offer novel products that enhance patient comfort and
safety to attract more users. For instance, the use of antibiotic coating in
central venous catheters has greatly reduced the risk of infection from the
catheter. Such instruments will be especially pertinent in the current market
scenario, since shrinking hospital budgets and low reimbursements levels are
making a case for highly technically innovative equipment that will reduce
the incision size and the duration of hospital care.

Budgetary constraints are also the reason that many hospitals favour bulk
buying of catheters and transducers. This puts manufacturers under pressure
to lower their prices, and thereby, their profit margins, they are hence,
resorting to outsourcing production to lower manufacturing costs. Market
participants can also garner higher revenues, retain existing clients and
expand their customer base by offering value-added services.

“Manufacturers and suppliers can train their technicians and servicing
staff in collaboration with medical institutes to improve the knowledge base
of service staff and subsequently, productivity,” notes Joshi. “Continuous
interactions between the medical staff and manufacturers through their sales
and marketing personnel will also aid the better understanding of the
products.”

European Market for Invasive Pressure Monitoring and Hemodynamic
Monitoring is part of the Patient Monitoring Growth Partnership Service
program, which also includes research in the following markets: European non
- invasive blood pressure monitoring market, European remote patient
monitoring market and European diagnostic cardiovascular monitoring equipment
market. All research services included in subscriptions provide detailed
market opportunities and industry trends that have been evaluated following
extensive interviews with market participants. Interviews with the press are
available.

GIL 2009: Europe

Frost & Sullivan has expanded its flagship Global Congress on Corporate
Growth - GIL Global - into several major cities around the world including
London. For the first time ever in Europe, Frost & Sullivan will be hosting
the Growth, Innovation and Leadership Congress ‘GIL 2009: Europe’ on 19-20
May, at the Sofitel St James in London. GIL Global is the industry’s only
event designed to support senior executives in their efforts to achieve
sustainable, top-line growth. To register, obtain a programme agenda, explore
sponsorship opportunities, or attend as a member of the media for GIL 2009:
Europe, please contact Katja Feick, Corporate Communications Europe, at
katja.feick@frost.com. One-on-One interviews with Frost & Sullivan senior
growth consultants are also being scheduled. For more information you can
also visit www.frost.com/gilglobal

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to
accelerate growth and achieve best in class positions in growth, innovation
and leadership. The company’s Growth Partnership Service provides the CEO and
the CEO’s Growth Team with disciplined research and best practice models to
drive the generation, evaluation and implementation of powerful growth
strategies. Frost & Sullivan leverages over 45 years of experience in
partnering with Global 1000 companies, emerging businesses and the investment
community from 31 offices on six continents. To join our Growth Partnership,
please visit www.frost.com.

European Market for Invasive Pressure Monitoring and
Hemodynamic Monitoring
M297

Contact:
Katja Feick
Corporate Communications - Europe
P: +49-(0)-69-7703343
E: katja.feick@frost.com
www.frost.com

Source: Frost & Sullivan

Katja Feick, Corporate Communications - Europe of Frost & Sullivan, +49-(0)-69-7703343, katja.feick at frost.com. Photo: https://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO